STXS Stock Analysis: Buy, Sell, or Hold?
STXS - Stereotaxis, Inc. Common Stock
$2.19
-0.14 (-6.01%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 02, 2026
28d
Get Alerted When STXS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: STXS is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: STXS is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: STXS is currently trading at $2.19, which is considered oversold relative to its 30-day fair value range of $2.36 to $2.69.
Technical Outlook: Technically, STXS is in a downtrend. The price is currently testing key support at $2.17. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.20 (+91.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STXS is in a downtrend. The price is currently testing key support at $2.17. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.20 (+91.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.36 -
$2.69
Company Quality Score
53/100
(HOLD)
Options IV Signal
11th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
82.1%
Protect Your Profits
Holding STXS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 11th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BULLISH: Trading 91.8% below Wall St target ($4.20)
- WARNING: Recommendation downgraded due to -18.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.36 -
$2.69
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.19
(8.9%)
Support & Resistance Levels
Support Level
$2.18
Resistance Level
$2.82
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-11.84
Wall Street Target
$4.20
(+91.8%)
Revenue Growth (YoY)
-18.8%
Profit Margin
-78.6%
Last updated: February 01, 2026 4:45 AM ET
Data refreshes hourly during market hours. Next update: 5:45 AM
Data refreshes hourly during market hours. Next update: 5:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STXS showing a specific setup today?
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced STXS Option Strategies
Professional options setups generated by AI based on today's STXS price and gamma walls.
